These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24351167)

  • 1. Artificial pancreas goes outpatient: a new diabetes ecosystem.
    Renard E; Cobelli C; Zisser HC; Kovatchev BP
    J Diabetes Sci Technol; 2013 Nov; 7(6):1411-5. PubMed ID: 24351167
    [No Abstract]   [Full Text] [Related]  

  • 2. Closed-loop artificial pancreas systems: engineering the algorithms.
    Doyle FJ; Huyett LM; Lee JB; Zisser HC; Dassau E
    Diabetes Care; 2014; 37(5):1191-7. PubMed ID: 24757226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The artificial pancreas: how close are we to closing the loop?
    Clarke WL; Kovatchev B
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078
    [No Abstract]   [Full Text] [Related]  

  • 4. Artificial pancreas: model predictive control design from clinical experience.
    Toffanin C; Messori M; Di Palma F; De Nicolao G; Cobelli C; Magni L
    J Diabetes Sci Technol; 2013 Nov; 7(6):1470-83. PubMed ID: 24351173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials.
    Place J; Robert A; Ben Brahim N; Keith-Hynes P; Farret A; Pelletier MJ; Buckingham B; Breton M; Kovatchev B; Renard E
    J Diabetes Sci Technol; 2013 Nov; 7(6):1427-35. PubMed ID: 24351169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
    Forlenza GP
    Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
    [No Abstract]   [Full Text] [Related]  

  • 7. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial pancreas: past, present, future.
    Cobelli C; Renard E; Kovatchev B
    Diabetes; 2011 Nov; 60(11):2672-82. PubMed ID: 22025773
    [No Abstract]   [Full Text] [Related]  

  • 9. The artificial pancreas.
    Brunetti P; Orsini Federici M; Massi Benedetti M
    Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):127-38. PubMed ID: 12751831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DiAs user interface: a patient-centric interface for mobile artificial pancreas systems.
    Keith-Hynes P; Guerlain S; Mize B; Hughes-Karvetski C; Khan M; McElwee-Malloy M; Kovatchev BP
    J Diabetes Sci Technol; 2013 Nov; 7(6):1416-26. PubMed ID: 24351168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The artificial pancreas in 2017: The year of transition from research to clinical practice.
    Kovatchev B
    Nat Rev Endocrinol; 2018 Feb; 14(2):74-76. PubMed ID: 29286043
    [No Abstract]   [Full Text] [Related]  

  • 12. Dexcom G4AP: an advanced continuous glucose monitor for the artificial pancreas.
    Garcia A; Rack-Gomer AL; Bhavaraju NC; Hampapuram H; Kamath A; Peyser T; Facchinetti A; Zecchin C; Sparacino G; Cobelli C
    J Diabetes Sci Technol; 2013 Nov; 7(6):1436-45. PubMed ID: 24351170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The closed-loop artificial pancreas in 2020.
    Fabris C; Kovatchev B
    Artif Organs; 2020 Jul; 44(7):671-679. PubMed ID: 32384582
    [No Abstract]   [Full Text] [Related]  

  • 15. The bionic pancreas: novel perspectives on insulin replacement therapies.
    Denecke C
    Transplantation; 2015 Feb; 99(2):268-9. PubMed ID: 25651115
    [No Abstract]   [Full Text] [Related]  

  • 16. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully automated artificial pancreas finally within reach.
    Hampton T
    JAMA; 2014 Jun; 311(22):2260-1. PubMed ID: 24870352
    [No Abstract]   [Full Text] [Related]  

  • 18. First use of model predictive control in outpatient wearable artificial pancreas.
    Del Favero S; Bruttomesso D; Di Palma F; Lanzola G; Visentin R; Filippi A; Scotton R; Toffanin C; Messori M; Scarpellini S; Keith-Hynes P; Kovatchev BP; Devries JH; Renard E; Magni L; Avogaro A; Cobelli C;
    Diabetes Care; 2014; 37(5):1212-5. PubMed ID: 24757228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minority groups and the artificial pancreas: who is (not) in line?
    Huyett L; Dassau E; Pinsker JE; Doyle FJ; Kerr D
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):880-881. PubMed ID: 27492758
    [No Abstract]   [Full Text] [Related]  

  • 20. Current management of diabetes mellitus and future directions in care.
    Chatterjee S; Davies MJ
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.